Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis
2018
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Triglycerides and Cardiovascular Disease
2011
Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure
2003
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
A guide to immunometabolism for immunologists
2016 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
HPS2-THRIVE results: Bad for niacin/laropiprant, good for ezetimibe?
2013
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Stent Thrombosis
2010
Hallmarks of aging: An expanding universe
2023 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
2020
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Statin Safety: An Assessment Using an Administrative Claims Database
2006
Guidelines for the Primary Prevention of Stroke
2010
Prevention of VTE in Nonsurgical Patients
2012 Standout
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia
1999
Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review
2012
Antithrombotic Therapy for VTE Disease
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Depression in Heart Failure
2006 Standout
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
2010
Update on strategies to increase HDL quantity and function
2009
Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism
2015
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
2011
Clopidogrel–Drug Interactions
2011
NAD+ homeostasis in health and disease
2020
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
2008
Obesity and the Risk of Heart Failure
2002 Standout
Clopidogrel and proton pump inhibitors - where do we stand in 2012?
2012
Lipoprotein(a) as a cardiovascular risk factor: current status
2010
A facile, sensitive and selective fluorescent probe for heparin based on aggregation-induced emission
2013
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Antiarrhythmics
2007
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
2009
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Quality of Life of Individuals With Heart Failure
2002
Acquired resistance to TKIs in solid tumours: learning from lung cancer
2014
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
G protein-coupled receptors for energy metabolites as new therapeutic targets
2012
The Current State of Niacin in Cardiovascular Disease Prevention
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Drug-related hypertension and resistance to antihypertensive treatment
2011
Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
2012
Stabilisation of atherosclerotic plaques
2011
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Combination therapy in dyslipidemia: Where are we now?
2014
Multidisciplinary strategies for the management of heart failure patients at high risk for admission
2004 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Antiplatelet Therapy and Proton Pump Inhibition
2012
Physical Activity Interventions Following Cancer Diagnosis: Methodologic Challenges to Delivery and Assessment
2004
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
A midlife stroke surge among women in the United States
2007
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
2011
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Sleep Apnea in 81 Ambulatory Male Patients With Stable Heart Failure
1998
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction
2000
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Thyroid Hormone Regulation of Metabolism
2014 Standout
Pathophysiology of Sleep Apnea
2010 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Sexual Activity and Cardiovascular Disease
2012
Works of Eric J. Stanek being referenced
Arterial oxygen saturation in chronic congestive heart failure
1994
Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
2009
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
2010
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
2016
Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation
2006
Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin
1995
Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
2010
Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival
2000
Patient Preferences for Thrombolytic Therapy in Acute Myocardial Infarction
1997
Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits
2013
Twelve-Month Frequency of Drug-Metabolizing Enzyme and Transporter-Based Drug-Drug Interaction Potential in Patients Receiving Oral Enzyme-Targeted Kinase Inhibitor Antineoplastic Agents
2013
Opportunity for Intervention to Achieve American Heart Association Guidelines for Optimal Lipid Levels in High-Risk Women in a Managed Care Setting
2005
Prolonged Quinidine Half‐life with Associated Toxicity in a Patient with Hepatic Failure
1997
SOURCES OF VARIANCE IN DAILY PHYSICAL ACTIVITY LEVELS IN THE SEASONAL VARIATION IN CHOLESTEROL STUDY
1998
Risk of cardiovascular events in patients at optimal values for combined lipid parameters
2007